Clerk of the House of Representatives
Legislative Resource Center
135 Cannon Building
Washington, DC 20515
http://lobbyingdisclosure.house.gov 		Secretary of the Senate
Office of Public Records
232 Hart Building
Washington, DC 20510
http://www.senate.gov/lobby
LOBBYING REPORT

Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

1. Registrant Name Organization/Lobbying Firm Self Employed Individual
Biogen

2. Address

Address1
701 PENNSYLVANIA AVENUE, NW #715
 Address2
​
City
WASHINGTON
 State
DC
 Zip Code
20004
 Country
USA

3. Principal place of business (if different than line 2)

City
​
State
​
Zip Code
​
Country
​
4a. Contact Name b. Telephone Number c. E-mail
​Mrs.
​Stephanie Dyson
​2023831447
​stephanie.dyson@biogen.com
5. Senate ID#
​48725-12
7. Client Name Self Check if client is a state or local government or instrumentality
​BIOGEN
6. House ID#
​345100000
TYPE OF REPORT 8. Year
​2019
 Q1 (1/1 - 3/31) Q2 (4/1 - 6/30) Q3 (7/1 - 9/30) Q4 (10/1 - 12/31)

9. Check if this filing amends a previously filed version of this report

10. Check if this is a Termination Report Termination Date
​
11. No Lobbying Issue Activity
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13
12. Lobbying 13. Organizations
INCOME relating to lobbying activities for this reporting period was: EXPENSE relating to lobbying activities for this reporting period were:
Less than $5,000
Less than $5,000
$5,000 or more $
​
$5,000 or more $
​266,680.00
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options.
Method A. Reporting amounts using LDA definitions only

Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code

Method C. Reporting amounts under section 162(e) of the Internal Revenue Code

Signature
Digitally Signed By: Stephanie Dyson
Date
1/22/2020 5:33:52 PM

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HCR

16. Specific lobbying issues

1. The Prescription Drug Pricing Reduction Act (PDPRA) of 2019 (entire bill) --
2. H.R. 3, Lower Drug Costs Now Act of 2019 (entire bill
3. Biosimilars Policy (no Bill). Advocacy for policy supporting/ that will spur the entry of biosimilars into the United States that will provide the Headroom for Innovation and is additive to the drug pricing policy debate.
4. Prescription Pricing for People Act (S. 1227/H.R. 2376) -SEC. 3. STUDY OF PHARMACEUTICAL SUPPLY CHAIN INTERMEDIARIES AND MERGER ACTIVITY as it pertains to PBMS and the supply chain.
5. Drug Rebate regulation - (no Bill) -Discussion regarding the Administrations withdrawal Harmful Drug Rebate Safe Harbor Rule, CBO Estimates,
6. Issues related to state based Newborn Screening Programs and tests (no Bill)
7. S.2543 - Prescription Drug Pricing Reduction Act of 2019

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS)

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Stephanie
Dyson
​
Deputy Office Director, OSORA CMS Special Assistant, COO, CMS
John
Gibson
​
​
Jon
Causey
​
Hon. Larry Bucshon - Chief of Staff, Senator Elizabeth Dole - Legislative Director--Hon. Patrick McHenry - Chief of Staff---Hon. Robin Hayes - Legislative Senator , Hon. Jesse Helms - Hon, Howard Coble
Michelle
Mathy
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MMM

16. Specific lobbying issues

Issues related to changes in the Medicare Part B reimbursement system;
issues related to changes in Iternational Pricing Index proposal; and
Administration and Congressional proposal to address rebates in the Medicare Part D program the Prescription Drug Pricing Reduction Act (PDPRA) of 2019 andH.R. 3, Lower Drug Costs Now Act of 2019).

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS)

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Stephanie
Dyson
​
Deputy Office Director, OSORA CMS Special Assistant, COO, CMS
John
Gibson
​
​
Jonathon
Causey
​
Hon. Larry Bucshon - Chief of Staff, Senator Elizabeth Dole - Legislative Director--Hon. Patrick McHenry - Chief of Staff---Hon. Robin Hayes - Legislative Senator , Hon. Jesse Helms - Hon, Howard Coble
Michelle
Mathy
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code TAX

16. Specific lobbying issues

Corporate tax requirements and jobs: Domestic and international tax policies that protect and incentivize U.S. based research and manufacturing jobs including the net cost of Biogen R & D and well as percentage of revenue spent on R &D.

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
John
Gibson
​
​
Stephanie
Dyson
​
Deputy Office Director, OSORA CMS Special Assistant, COO, CMS
Jonathon
Causey
​
Hon. Larry Bucshon - Chief of Staff, Senator Elizabeth Dole - Legislative Director--Hon. Patrick McHenry - Chief of Staff---Hon. Robin Hayes - Legislative Senator , Hon. Jesse Helms - Hon, Howard Coble
Michelle
Mathy
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code TRD

16. Specific lobbying issues

IP protections for biologics and pharmaceuticals, consistent with U.S. law, to be included in trade agreements.

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Stephanie
Dyson
​
Deputy Office Director, OSORA CMS Special Assistant, COO, CMS
John
Gibson
​
​
Jonathon
Causey
​
Hon. Larry Bucshon - Chief of Staff, Senator Elizabeth Dole - Legislative Director--Hon. Patrick McHenry - Chief of Staff---Hon. Robin Hayes - Legislative Senator , Hon. Jesse Helms - Hon, Howard Coble
Michelle
Mathy
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code CPT

16. Specific lobbying issues

S.1416 - Affordable Prescriptions for Patients Act of 2019 pertaining to the U.S. Patent system and well as patent law as it pertains to the IP system/process.SEC. 106. RESTORATION OF PATENTS AS PROPERTY RIGHTS. Entire Bill with particular emphasis on Secti 2, product hoping and patent thickening

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
stephanie
Dyson
​
Deputy Office Director, OSORA CMS Special Assistant, COO, CMS
John
Gibson
​
​
Jonathon
Causey
​
Hon. Larry Bucshon - Chief of Staff, Senator Elizabeth Dole - Legislative Director--Hon. Patrick McHenry - Chief of Staff---Hon. Robin Hayes - Legislative Senator , Hon. Jesse Helms - Hon, Howard Coble
Michelle
Mathy
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

Address
​701 Pennsylvania Ave. N.W #715
City
​Washington,
State
​DC
 Zip Code
​20004
 Country
​USA

21. Client new principal place of business (if different than line 20)

City
​
State
​
Zip Code
​
Country
​

22. New General description of client’s business or activities

​

LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

First Name
Last Name
Suffix
First Name
Last Name
Suffix
1
​
​
​
3
​
​
​
2
​
​
​
4
​
​
​

ISSUE UPDATE

24. General lobbying issue that no longer pertains

​
​
​
​
​
​
​
​
​

AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address:

Name Address Principal Place of Business
(city and state or country)
Street Address
City State/Province Zip Country
City
State Country

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

1 2 3

FOREIGN ENTITIES

27. Add the following foreign entities:

Name Address Principal place of business
(city and state or country) 		Amount of contribution for lobbying activities Ownership percentage in client
Street Address
City State/Province Country
City
State Country
%

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization

1 3 5
2 4 6

CONVICTIONS DISCLOSURE

29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery, extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?

Lobbyist Name Description of Offense(s)